TrialPLoS neglected tropical diseases2021

Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).

Jaime Altcheh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.